AstraZeneca vaccine: Germany OKs Astra for over-65s, extends gap between doses | World News – Times of India
[ad_1]
BERLIN: Germany’s vaccination authority has approved the use of AstraZeneca’s coronavirus vaccine on the over-65s, the health ministry said on Thursday, in a step that should help accelerate the country’s faltering inoculation drive. It added that the Permanent Vaccination Commission had recommended extending to a maximum 12 weeks the period between receiving the first and second doses of the AstraZeneca shot on the back of studies showing a longer gap improved its efficacy. “This is good news for older people who are waiting for a vaccine. They can now be vaccinated more quickly,” health minister Jens Spahn said in a statement. “We will shortly issue a regulation implementing both recommendations.”
People who have recovered from Covid-19 should receive a single dose of the AstraZeneca shot six months after their diagnosis, the Vaccination Commission said in a statement issued via the Robert Koch Institute for infectious diseases. The ruling follows a similar moves in Spain, France, Italy and Sweden and accounts for the immunity engendered in patients who have recovered from the flu-like disease. Germany declined initially to authorise AstraZeneca’s vaccine for those aged above 65, saying there was a lack of evidence from clinical trials confirming its effectiveness.
Growing data showing the AstraZeneca shot’s efficacy among the elderly in Britain led to the change of heart in Berlin, while France also eased a ban this week on giving the shot to people over the age of 65.
People who have recovered from Covid-19 should receive a single dose of the AstraZeneca shot six months after their diagnosis, the Vaccination Commission said in a statement issued via the Robert Koch Institute for infectious diseases. The ruling follows a similar moves in Spain, France, Italy and Sweden and accounts for the immunity engendered in patients who have recovered from the flu-like disease. Germany declined initially to authorise AstraZeneca’s vaccine for those aged above 65, saying there was a lack of evidence from clinical trials confirming its effectiveness.
Growing data showing the AstraZeneca shot’s efficacy among the elderly in Britain led to the change of heart in Berlin, while France also eased a ban this week on giving the shot to people over the age of 65.
[ad_2]
Source link
Comments are closed.